Mounjaro (tirzepatide) 12.5 mg
Mounjaro (tirzepatide) 12.5 mg is a treatment for type 2 diabetes, combining GIP and GLP-1 receptor agonist actions. It improves blood sugar control by increasing insulin secretion, lowering glucose production, and slowing gastric emptying. This dual-action approach helps manage blood sugar levels effectively in adults with type 2 diabetes.
more information – https://www.elliepharma.com/product-page/mounjaro-tirzepatide-12-5mg